NCT00882752

Brief Summary

The method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections. Therefore, this methodology may prove useful to other researchers or physicians.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2008

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2008

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 29, 2008

Completed
7 months until next milestone

First Posted

Study publicly available on registry

April 16, 2009

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

September 7, 2011

Status Verified

September 1, 2011

Enrollment Period

1.8 years

First QC Date

September 29, 2008

Last Update Submit

September 6, 2011

Conditions

Molecular Analysis

Keywords

Ulcerative Colitis (UC)

Outcome Measures

Primary Outcomes (1)

  • The method used for the biopsy analysis may be able to provide important insights into the complex microbial communities found in the human colon or in complex human infections.

    1 year

Study Arms (1)

Ulcerative colitius

The method used to identify the microbes in the sample was chosen because it had the potential to provide more exhaustive identification of the bacteria present in the sample as compared to culturing methodology.

Procedure: molecular analysis

Interventions

molecular analysisPROCEDURE

bowel disease

Ulcerative colitius

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

People with ulcerative colitis.

You may qualify if:

  • Diagnosis of ulcerative colitis
  • Age \>= 18 years old
  • Female

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

colon biopsy

MeSH Terms

Conditions

Colitis, Ulcerative

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Randall Wolcott, MD

    Southwest Regional Wound Care

    PRINCIPAL INVESTIGATOR

  • Randall Wolcott, MD

    Southwest Regional Wound Care Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

September 29, 2008

First Posted

April 16, 2009

Study Start

January 1, 2008

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

September 7, 2011

Record last verified: 2011-09